 |
|
|
| |
Similar Declines in HIV-1 RNA (Viral load, VL) from
Baseline (BL) to 96 Weeks Observed in Subjects
Randomized to ABC/3TC or TDF/FTC each with
Lopinavir/Ritonavir (LPV/r) in the HEAT Trial (EPZ104057)
|
| |
| |
Reported by Jules Levin
5th IAS Capetown July 19-22 2009
Linda Yau1, Jaime Hernandez2, Parul Patel1, Lynn Dix1, Keith Pappa1, and Mark Shaefer1
1GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina, USA; 2BioCryst Pharmaceuticals, Inc., Cary, North Carolina, USA.
|
| |
|
|
|
|
|
